Fecal Microbiota Transplantation for Recurrent C difficile Infection During the COVID-19 Pandemic

Evidence for gastrointestinal infection of SARS-CoV-2

(2020) Fei Xiao et al.   GASTROENTEROLOGY

The Novel Coronavirus Originating in Wuhan, China

(2020) Alexandra L. Phelan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Digestive Symptoms in COVID-19 Patients With Mild Disease Severity

(2020) Chaoqun Han et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection

(2020) Sahil Khanna et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Evaluation of Saline, Phosphate-Buffered Saline, and Minimum Essential Medium as Potential Alternatives to Viral Transport Media for SARS-CoV-2 Testing

(2020) Kyle G. Rodino et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

(2020) Kelvin Kai-Wang To et al.   LANCET INFECTIOUS DISEASES

Update on Treatment of Clostridioides difficile Infection

(2020) Janice M. Cho et al.   MAYO CLINIC PROCEEDINGS

Fair Allocation of Scarce Medical Resources in the Time of Covid-19

(2020) Ezekiel J. Emanuel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prolonged presence of SARS-CoV-2 viral RNA in faecal samples

(2020) Yongjian Wu et al.   Lancet Gastroenterology & Hepatology

Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic

(2020) Gianluca Ianiro et al.   GUT

Prevalence and Mortality of COVID-19 Patients With Gastrointestinal Symptoms: A Systematic Review and Meta-analysis

(2020) Raseen Tariq et al.   MAYO CLINIC PROCEEDINGS

Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis

(2019) Wenjia Hui et al.   PLoS One

Increasing antibiotic resistance in Clostridioides difficile: A systematic review and meta-analysis

(2019) Srishti Saha et al.   ANAEROBE

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence

(2018) Dale N Gerding et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

(2018) L Clifford McDonald et al.   CLINICAL INFECTIOUS DISEASES

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial

(2018) Benoit Guery et al.   LANCET INFECTIOUS DISEASES

Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing

(2017) Zhong Peng et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection

(2016) Colleen R. Kelly et al.   ANNALS OF INTERNAL MEDICINE

Donor Screening Experience for Fecal Microbiota Transplantation in Patients With Recurrent C. difficile Infection

(2016) Raseen Tariq et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Cost-effectiveness of Competing Strategies for Management of Recurrent Clostridium difficile Infection: A Decision Analysis

(2014) Gauree G. Konijeti et al.   CLINICAL INFECTIOUS DISEASES

Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies

(2014) M. M. Soriano et al.   Open Forum Infectious Diseases